Vita 34 AG (V3V):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Vita 34 AG (V3V) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3476
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vita 34 AG (Vita 34), formerly Vita 34 International AG, is an umbilical cord blood bank that collects, prepares, processes, deposits, and stores stem cells from umbilical cord blood. The company’s products comprise vitaplus, vitaplus25, vitaplus50, vitapluscordtissue, vitapluscordtissue25, and vitapluscordtissue50. Vita 34 conducts research on umbilical cord blood used in acquired hearing loss, early childhood brain damage, aplastic anemia, blood cancer, solid tumors, type 1 diabetes, and gene therapy for severe immune deficiency. The company also provides vitaplus donation, and preventive screening services. It has operations in the US, Austria, Switzerland and Spain. Vita 34 is headquartered in Leipzig, Germany.

Vita 34 AG (V3V) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vita 34 AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vita 34 AG, Medical Devices Deals, 2012 to YTD 2018 9
Vita 34 AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Vita 34 AG, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Vita 34 to Acquire Assets from Vivocell Biosolutions for USD0.8 Million 11
Equity Offering 12
Vita 34 Raises USD5.4 Million in Rights Offering of Shares 12
Acquisition 13
VITA 34 Acquires 100% Stake in Seracell Pharma 13
Vita 34 Acquires 30% Stake in Bio Save 14
VITA 34 Acquires 75.24% Stake In Stellacure 15
Medivision Acquires 51% Stake In Stellacure From Cord Blood America 16
VITA 34 Acquires BioPlanta, Developer Of Active Herbal Ingredients 17
Vita 34 AG – Key Competitors 18
Vita 34 AG – Key Employees 19
Vita 34 AG – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 08, 2017: Vita 34 adjusts revenues and earnings targets for 2017 21
Feb 01, 2017: Vita 34 increased its turnover in 2016 by 14 per cent in comparison to the previous year 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Vita 34 AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vita 34 AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vita 34 AG, Deals By Therapy Area, 2012 to YTD 2018 8
Vita 34 AG, Medical Devices Deals, 2012 to YTD 2018 9
Vita 34 AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Vita 34 to Acquire Assets from Vivocell Biosolutions for USD0.8 Million 11
Vita 34 Raises USD5.4 Million in Rights Offering of Shares 12
VITA 34 Acquires 100% Stake in Seracell Pharma 13
Vita 34 Acquires 30% Stake in Bio Save 14
VITA 34 Acquires 75.24% Stake In Stellacure 15
Medivision Acquires 51% Stake In Stellacure From Cord Blood America 16
VITA 34 Acquires BioPlanta, Developer Of Active Herbal Ingredients 17
Vita 34 AG, Key Competitors 18
Vita 34 AG, Key Employees 19
Vita 34 AG, Subsidiaries 20

List of Figures
Vita 34 AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vita 34 AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vita 34 AG, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Vita 34 AG (V3V):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • LifeWatch AG (LIFE)-医療機器分野:企業M&A・提携分析
    Summary LifeWatch AG (LifeWatch) is a healthcare technology and solutions company. It provides monitoring services and develops, manufactures, and markets advanced telehealth systems for high-risk and chronically ill patients. The company’s major services include mobile cardiac telemetry service, st …
  • Rosneft Oil Co (ROSN):電力:M&Aディール及び事業提携情報
    Summary Rosneft Oil Company (Rosneft) is a vertically integrated oil and gas company that explores for, develops and produces crude oil, natural gas and condensates; and refines, markets and distributes petroleum products and petrochemicals. It has exploration assets across Western Siberia, Eastern …
  • The Akita Bank Ltd:企業の戦略・SWOT・財務情報
    The Akita Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Akita Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Candover Investments plc:企業の戦略的SWOT分析
    Candover Investments plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Aecon Group Inc (ARE):企業の財務・戦略的SWOT分析
    Aecon Group Inc (ARE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Oglethorpe Power Corporation:発電所・企業SWOT分析
    Oglethorpe Power Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Indeck Energy Services Inc:企業の発電所・SWOT分析2018
    Indeck Energy Services Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • PG&E Corp (PCG):企業の財務・戦略的SWOT分析
    PG&E Corp (PCG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Aspen Technology, Inc. (AZPN):企業の財務・戦略的SWOT分析
    Aspen Technology, Inc. (AZPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Origin Energy Ltd (ORG):企業の財務・戦略的SWOT分析
    Origin Energy Ltd (ORG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Coal India Ltd:企業のM&A・事業提携・投資動向
    Coal India Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Coal India Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Berkley Renewables Inc (BKS)-石油・ガス分野:企業M&A・提携分析
    Summary Berkley Renewables Inc (Berkley) is a venture firm that focuses on capturing opportunities in renewable energy, life sciences, and oil & gas sectors. The company essentially carries out power generation through the management and operation of solar photovoltaic plants . It also undertakes th …
  • Shinsei Bank Ltd:戦略・SWOT・企業財務分析
    Shinsei Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Shinsei Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Azul SA (AZUL):企業の財務・戦略的SWOT分析
    Azul SA (AZUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Kellogg Co:戦略・SWOT・企業財務分析
    Kellogg Co - Strategy, SWOT and Corporate Finance Report Summary Kellogg Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Xvivo Perfusion AB (XVIVO):企業の財務・戦略的SWOT分析
    Summary Xvivo Perfusion AB (Xvivo) is a medical technology company that provides organ transplantation solutions. The company develops organ preservation products such as perfadex and silicone tubing sets and normothermic perfusion products. It offers normothermic perfusion products such as STEEN so …
  • ProSciento Inc-医療機器分野:企業M&A・提携分析
    Summary ProSciento Inc (ProSciento), formerly Profil Institute for Clinical Research Inc is contract research organization that concentrates on developing drugs and devices for the treatment of obesity, diabetes and metabolic diseases. The organization offers services such as clinical development an …
  • Sosei Group Corp (4565):製薬・医療:M&Aディール及び事業提携情報
    Summary Sosei Group Corp (Sosei) is a biopharmaceutical company that develops and commercializes drugs. The company’s pipeline products include NorLevo, NVA237, QVA149 and SO-1105. Its NorLevo product is an oral emergency contraceptive; and SO-1105 is an antifungal agent, administered as a muco-adhe …
  • Quest Diagnostics Inc (DGX):製薬・医療:M&Aディール及び事業提携情報
    Summary Quest Diagnostics Inc (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a chain of laboratories and company-owned patient service centers. It offers comprehensive range of services including clinical testing with gene-based and other esot …
  • Al Ghubrah Power and Desalination Company:企業の戦略的SWOT分析
    Al Ghubrah Power and Desalination Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆